Around the Net
Marketing Of Female Libido Drug Bungled
- Bloomberg, Thursday, November 3, 2016 8 AM
Valeant Pharmaceuticals was sued by former investors of Sprout Pharmaceuticals over claims the company bungled the marketing of a female libido pill it acquired from Sprout in a $1 billion buyout of the drugmaker. The lawsuit claims Valeant violated terms by overcharging for Addyi and failed to make promised investments to market the drug.
